Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients

Current Problems in Cancer - Tập 45 - Trang 100709 - 2021
Menha Swellam1, Hekmat M EL Magdoub2, May A Shawki3, Marwa Adel3, Mona M Hefny4, Samar Sami El-Shazly5
1High Throughput Molecular and Genetic Laboratory, Center for Excellence for Advanced Sciences, Biochemistry Department, Genetic Engineering and Biotechnology Research Division, National Research Centre, Dokki, Giza, Egypt.
2Biochemistry Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt
3Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
4Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
5Clinical Pathology Department, National Cancer Institute, Cairo, Egypt

Tài liệu tham khảo

Kazarian, 2017, Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples, Br J Cancer, 116, 501, 10.1038/bjc.2016.433 Eng, 2014, Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis, PLoS Med, 11, 10.1371/journal.pmed.1001720 Dey, 2010, Urban-rural differences in breast cancer incidence in Egypt (1999-2006), Breast, 19, 417, 10.1016/j.breast.2010.04.005 Uddin, 2012, Public and professional educational needs for downstaging breast cancer in Egypt, J Cancer Educ, 27, 149, 10.1007/s13187-011-0282-3 Loke, 2018, The future of blood-based biomarkers for the early detection of breast cancer, Eur J Cancer, 92, 54, 10.1016/j.ejca.2017.12.025 Welch, 2016, Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness, N Engl J Med, 375, 1438, 10.1056/NEJMoa1600249 Boyd, 2007, Mammographic density and the risk and detection of breast cancer, N Engl J Med, 356, 227, 10.1056/NEJMoa062790 Forrest, 2017, Review: regulation of the cancer epigenome by long non-coding RNAs, Cancer Lett, 407, 106, 10.1016/j.canlet.2017.03.040 Kondo, 2017, Long non-coding RNAs as an epigenetic regulator in human cancers, Cancer Sci, 108, 1927, 10.1111/cas.13342 Beckedorff, 2013, Long non-coding RNAs and their implications in cancer epigenetics, Biosci Rep, 33, 667, 10.1042/BSR20130054 Kumar, 2016, Molecular and cellular changes in breast cancer and new roles of lncRNAs in breast cancer initiation and progression, Prog Mol Biol Transl Sci, 144, 563, 10.1016/bs.pmbts.2016.09.011 Zhao, 2017, NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression, Cancer Biomark, 20, 247, 10.3233/CBM-170027 Arshi, 2018, Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer tissues from young women and women over 45 years of age, Mol Ther Nucleic Acids, 12, 751, 10.1016/j.omtn.2018.07.014 Jiang, 2018, NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1, J Cell Physiol, 233, 8558, 10.1002/jcp.26470 Choudhry, 2015, Tumor hypoxia induces nuclear paraspeckle formation through HIF-2alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival, Oncogene, 34, 4482, 10.1038/onc.2014.378 Li, 2017, The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer, Int J Biol Macromol, 105, 346, 10.1016/j.ijbiomac.2017.07.053 Zhang, 2017, lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT, Eur Rev Med Pharmacol Sci, 21, 1020 Sun, 2017, LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis, Cell Cycle, 16, 2100, 10.1080/15384101.2017.1361071 Tang, 2017, lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP, Oncol Rep, 38, 941, 10.3892/or.2017.5751 Tantai, 2015, Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer, Int J Clin Exp Pathol, 8, 7887 Schouten, 2016, High XIST and low 53BP1 expression predict poor outcome after high-dose alkylating chemotherapy in patients with a BRCA1-like breast cancer, Mol Cancer Ther, 15, 190, 10.1158/1535-7163.MCT-15-0470 Greene, 2008, The staging of cancer: a retrospective and prospective appraisal, CA Cancer J Clin, 58, 180, 10.3322/CA.2008.0001 Robbins, 1995, Histological grading of breast carcinomas: a study of interobserver agreement, Hum Pathol, 26, 873, 10.1016/0046-8177(95)90010-1 Hsu, 1981, A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies, Am J Clin Pathol, 75, 734, 10.1093/ajcp/75.5.734 Kim, 2008, Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer, Acta Oncologica, 47, 1531, 10.1080/02841860801971413 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Zweig, 1993, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin Chem, 39, 561, 10.1093/clinchem/39.4.561 Mattick, 2006, Non-coding RNA, Hum Mol Genet, 15, R17, 10.1093/hmg/ddl046 Wang, 2018, A potential prognostic long noncoding RNA signature to predict recurrence among ER-positive breast cancer patients treated with tamoxifen, Sci Rep,, 8, 3179, 10.1038/s41598-018-21581-w Richard, 2018, Deciphering the roles of lncRNAs in breast development and disease, Oncotarget, 9, 20179, 10.18632/oncotarget.24591 Zhang, 2018, Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer, Thorac Cancer, 9, 66, 10.1111/1759-7714.12537 Schwarzenbach, 2011, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, 11, 426, 10.1038/nrc3066 van der Vaart, 2008, Circulating DNA. Its origin and fluctuation, Ann N Y Acad Sci, 1137, 18, 10.1196/annals.1448.022 Shi, 2016, Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics, Dis Mark, 2016 Zhang, 2017, The value of lncRNA NEAT1 as a prognostic factor for survival of cancer outcome: a meta-analysis, Sci Rep,, 7, 13080, 10.1038/s41598-017-10001-0 Mao, 2018, Prognostic role of long non-coding RNA XIST expression in patients with solid tumors: a meta-analysis, Cancer Cell Int, 18, 34, 10.1186/s12935-018-0535-x Takahashi, 2014, Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer, FEBS Open Bio, 4, 458, 10.1016/j.fob.2014.04.007 Perkins, 2004, Association between breast cancer laterality and tumor location, United States, 1994-1998, Cancer Causes Control, 15, 637, 10.1023/B:CACO.0000036171.44162.5f Arkoob, 2010, Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis, East Mediterr Health J, 16, 1032, 10.26719/2010.16.10.1032 Samir, 2018, The long non-coding RNA XIST: a new cornerstone in carcinogenesis, J Mol Genet Med, 12 Malhotra, 2017, The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer, Oncotarget, 8, 110671, 10.18632/oncotarget.22577